The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling ; volume:22 ; number:1 ; day:12 ; month:3 ; year:2024 ; pages:1-18 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (12.3.2024), 1-18, 12.2024

Creator: Li, Tianye
Niu, Mengke
Zhou, Jianwei
Wu, Kongming
Yi, Ming

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12964-024-01562-5

URN: urn:nbn:de:101:1-2405150828198.073700110133

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Li, Tianye
Niu, Mengke
Zhou, Jianwei
Wu, Kongming
Yi, Ming
SpringerLink (Online service)

Other Objects (12)

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Related objects

Reset password